Brooke Moore
Pediatric Pulmonology · Minneapolis, MNNPI 1568662195
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations.
Across 30 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$62
- AstraZeneca$52
- AbbVie$50
- Baxter Healthcare$48
- Alcresta Therapeutics, Inc.$46
- Vertex$44
- plus $214 from 10 others
Across 34 payments — averaging $32,740 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$1.1M
What the payments were for
- Food & beverage$516100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 3 | $62 |
| AstraZeneca | 4 | $52 |
| AbbVie | 3 | $50 |
| Baxter Healthcare | 2 | $48 |
| Alcresta Therapeutics, Inc. | 2 | $46 |
| Vertex | 3 | $44 |
| Sanofi | 2 | $44 |
| Genentech USA, Inc. | 2 | $26 |
| Ambu Inc. | 1 | $26 |
| Electromed, Inc. | 2 | $22 |
| Gilead | 1 | $20 |
| Amgen | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Philips North America LLC | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
How this compares
Too few pediatric pulmonology providers in Minnesotato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azithromycin | 13 | $135 |
Paid to pharmacies, not to this prescriber.
Other pediatric pulmonology in Minneapolis
- Samuel GoldfarbMinneapolis$11K
- John McNamaraMinneapolis$3K
- Keith CavanaughMinneapolis$2K
- Zachary JohnsonMinneapolis$1K
- Anne GriffithsMinneapolis$518
- Daniela ZghereaMinneapolis$500
- Nandini KatariaMinneapolis$395
- Michael PryorMinneapolis$354
- Michael ShreveMinneapolis$322
- Megan LambertMinneapolis$250
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.